OBiO has always been adhering to the objective of "integrate your and my resources, serve for life science", under the business model of "Multi-cooperation + research service + industrial support", providing overall solution of viral based gene therapy CRO services, and CDMO/CMO services for gene drug production, for the domestic universities and scientific research institutions, medical institutions and pharmaceutical companies.
With the strategy of “build a platform, promote gene therapy industry”, OBiO has collaborated with GE Healthcare since March 29th, 2017, to set up the first domestic GMP viral production workshop in China (>5,000 ㎡), for CRO/CDMO/CMO services of viral drugs. Meanwhile, OBiO also focus on incubating gene therapy drugs for cancer therapy. By now, OBiO has got 3 candidate ADC drugs for oncotherapy with proprietary intellectual property rights.
Under the vision of "let gene therapy benefit humans", OBiO is ready to collaborate with you from all over the world.